Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Citing this Article

Right click to copy or hit: ctrl+c (cmd+c on mac)

Published on 13.07.17 in Vol 6, No 7 (2017): July

This paper is in the following e-collection/theme issue:

Works citing "Treatment of Peritoneal Dissemination in Stomach Cancer Patients With Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Rationale and Design of the PERISCOPE Study"

According to Crossref, the following articles are citing this article (DOI 10.2196/resprot.7790):

(note that this is only a small subset of citations)

  1. Brenkman HJF, Gertsen EC, Vegt E, van Hillegersberg R, van Berge Henegouwen MI, Gisbertz SS, Luyer MDP, Nieuwenhuijzen GAP, van Lanschot JJB, Lagarde SM, de Steur WO, Hartgrink HH, Stoot JHMB, Hulsewe KWE, Spillenaar Bilgen EJ, van Det MJ, Kouwenhoven EA, van der Peet DL, Daams F, van Sandick JW, van Grieken NCT, Heisterkamp J, van Etten B, Haveman JW, Pierie JP, Jonker F, Thijssen AY, Belt EJT, van Duijvendijk P, Wassenaar E, van Laarhoven HWM, Wessels FJ, Haj Mohammad N, van Stel HF, Frederix GWJ, Siersema PD, Ruurda JP. Evaluation of PET and laparoscopy in STagIng advanced gastric cancer: a multicenter prospective study (PLASTIC-study). BMC Cancer 2018;18(1)
    CrossRef
  2. . Surgery with curative intent for stage IV gastric cancer: Is it a reality of illusion?. Annals of Gastroenterological Surgery 2018;2(5):339
    CrossRef
  3. Paredes AZ, Guzman-Pruneda FA, Abdel-Misih S, Hays J, Dillhoff ME, Pawlik TM, Cloyd JM. Perioperative Morbidity of Gastrectomy During CRS-HIPEC: An ACS-NSQIP Analysis. Journal of Surgical Research 2019;241:31
    CrossRef
  4. BARCHI LC, RAMOS MFKP, DIAS AR, YAGI OK, RIBEIRO-JÚNIOR U, ZILBERSTEIN B, CECCONELLO I. TOTAL OMENTECTOMY IN GASTRIC CANCER SURGERY: IS IT ALWAYS NECESSARY?. ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo) 2019;32(1)
    CrossRef
  5. Koemans WJ, van der Kaaij RT, Boot H, Buffart T, Veenhof AAFA, Hartemink KJ, Grootscholten C, Snaebjornsson P, Retel VP, van Tinteren H, Vanhoutvin S, van der Noort V, Houwink A, Hahn C, Huitema ADR, Lahaye M, Los M, van den Barselaar P, Imhof O, Aalbers A, van Dam GM, van Etten B, Wijnhoven BPL, Luyer MDP, Boerma D, van Sandick JW. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy versus palliative systemic chemotherapy in stomach cancer patients with peritoneal dissemination, the study protocol of a multicentre randomised controlled trial (PERISCOPE II). BMC Cancer 2019;19(1)
    CrossRef
  6. Zhao B, Mei D, Zhang J, Zou S, Lu H, Xu H, Huang B. The prognostic significance of macroscopic serosal change in subserosal invasion (stage T3) gastric cancer. The Annals of The Royal College of Surgeons of England 2019;101(4):249
    CrossRef
  7. Koemans W, van der Kaaij R, Wassenaar E, Grootscholten C, Boot H, Boerma D, Los M, Imhof O, Schellens J, Rosing H, Huitema A, van Sandick J. Systemic exposure of oxaliplatin and docetaxel in gastric cancer patients with peritonitis carcinomatosis treated with intraperitoneal hyperthermic chemotherapy. European Journal of Surgical Oncology 2021;47(2):486
    CrossRef
  8. Kaaij RT, Wassenaar ECE, Koemans WJ, Sikorska K, Grootscholten C, Los M, Huitema A, Schellens JHM, Veenhof AAFA, Hartemink KJ, Aalbers AGJ, Ramshorst B, Boerma D, Boot H, Sandick JW. Treatment of PERItoneal disease in Stomach Cancer with cytOreductive surgery and hyperthermic intraPEritoneal chemotherapy: PERISCOPE I initial results. British Journal of Surgery 2020;107(11):1520
    CrossRef
  9. Koemans WJ, Houwink A, van der Kaaij RT, Wassenaar ECE, Boerma D, Hahn C, Imhof O, Brandt MG, Ariëns MP, Veenhof AAFA, Hartemink KJ, van Sandick JW. Perioperative Management of Gastric Cancer Patients Treated With (Sub)Total Gastrectomy, Cytoreductive Surgery, and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Lessons Learned. Annals of Surgical Oncology 2021;28(8):4647
    CrossRef
  10. Koemans W, van der Kaaij R, Wassenaar EE, Boerma D, Boot H, Sikorska K, Los M, Grootscholten C, Hartemink K, Veenhof AFA, Kodach L, Snaebjornsson P, van Sandick J. Tumor characteristics and clinical outcome of peritoneal metastasis of gastric origin treated with a hyperthermic intraperitoneal chemotherapy procedure in the PERISCOPE I trial. Journal of Surgical Oncology 2021;123(4):904
    CrossRef
  11. Polkowski WP, Rawicz-Pruszynski K, Mielko J, Geca K, Skorzewska M, Cisel B. Treatment of peritoneal metastases from gastric carcinoma. Current Issues in Pharmacy and Medical Sciences 2017;30(4):173
    CrossRef
  12. Gantsev SK, Gantsev KS, Kzyrgalin SR, Ishmuratova KR. Peritoneal Canceromatosis in Malignant Tumors of Various Localizations. Achievements and Prospects. Creative surgery and oncology 2021;11(2):149
    CrossRef
  13. Sammartino P, De Manzoni G, Marano L, Marrelli D, Biacchi D, Sommariva A, Scaringi S, Federici O, Guaglio M, Angrisani M, Cardi M, Fassari A, Casella F, Graziosi L, Roviello F. Gastric Cancer (GC) with Peritoneal Metastases (PMs): An Overview of Italian PSM Oncoteam Evidence and Study Purposes. Cancers 2023;15(12):3137
    CrossRef

According to Crossref, the following books are citing this article (DOI 10.2196/resprot.7790):

  1. Bogach J, McCart A, Bischof D, Govindarajan A. Surgical Oncology Manual. 2020. Chapter 22:437
    CrossRef
  2. . Multidisciplinary Approach to Surgical Oncology Patients. 2021. Chapter 40:325
    CrossRef